🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,187

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

21 results for “Harmony Biosciences Holdings” Clear

  1. Clemizole HCl

    Harmony Biosciences Holdings

    Lennox Gastaut Syndrome

    phase 3 small molecule active

    1 trial
  2. Clemizole HCl

    Harmony Biosciences Holdings

    Dravet Syndrome

    phase 3 small molecule active

    1 trial
  3. HBS-101, White, round, plain, biconvex film-coated tablet. Matching 4.45 mg tablet is 3.7 mm in diameter., White, round, plain, biconvex film-coated tablet. matching 17.8 mg tablet is 7.5 mm in diameter., WAKIX, HBS-101, WAKIX

    Harmony Biosciences Holdings

    Prader-Willi syndrome

    phase 3 small molecule active

    1 trial
  4. HBS-301 tablet

    Harmony Biosciences Holdings

    Idiopathic Hypersomnia

    phase 3 small molecule active

    1 trial
  5. Open-label pitolisant

    Harmony Biosciences Holdings

    Idiopathic Hypersomnia

    phase 3 small molecule completed

    1 trial
  6. Pitolisant

    Harmony Biosciences Holdings

    Idiopathic Hypersomnia

    phase 3 small molecule completed

    1 trial
  7. Pitolisant

    Harmony Biosciences Holdings

    Prader-Willi Syndrome

    phase 3 small molecule active

    1 trial
  8. Pitolisant tablet

    Harmony Biosciences Holdings

    Prader-Willi Syndrome

    phase 3 small molecule active

    1 trial
  9. ZYN002 Transdermal Gel Cannabidiol (CBD)

    Harmony Biosciences Holdings

    Fragile X Syndrome (FXS)

    phase 3 small molecule active

    1 trial
  10. ZYN002 Transdermal Gel Cannabidiol (CBD), ZYN002 Placebo Transdermal Gel

    Harmony Biosciences Holdings

    Fragile X syndrome (FXS)

    phase 3 small molecule active

    1 trial
  11. OVX836 480µg

    Harmony Biosciences Holdings

    Influenza

    phase 2 mab completed

    1 trial
  12. OVX836 shot

    Harmony Biosciences Holdings

    Vaccine-Preventable Diseases

    phase 2 mab completed

    1 trial
  13. Pitolisant Oral Tablet

    Harmony Biosciences Holdings

    Myotonic Dystrophy 1

    phase 2 small molecule completed

    1 trial
  14. Pitolisant oral tablets

    Harmony Biosciences Holdings

    Prader-Willi Syndrome

    phase 2 small molecule completed

    1 trial
  15. ZYN002

    Harmony Biosciences Holdings

    22Q11.2 Deletion Syndrome

    phase 2 small molecule completed

    1 trial
  16. HBS-201

    Harmony Biosciences Holdings

    Narcolepsy

    phase 1 small molecule completed

    1 trial
  17. MV-LASV

    Harmony Biosciences Holdings

    Lassa Virus Infection

    phase 1 mab completed

    1 trial
  18. Part 1

    Harmony Biosciences Holdings

    Drug Interaction

    phase 1 small molecule completed

    1 trial
  19. Pitolisant

    Harmony Biosciences Holdings

    Restless Legs Syndrome

    approved small molecule active

    1 trial
  20. Complex with Biotin 5,000 mcg, Collagen, Keratin and Hyaluronic Acid.

    Harmony Biosciences Holdings

    Hair Thinning

    other active

    1 trial
  21. Complex with Biotin, Collagen, Keratin, Hyaluronic Acid.

    Harmony Biosciences Holdings

    Hair Thinning

    other completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources